Argos Therapeutics, Inc. (ARGS)

Trade ARGS now with
4/19/2018 8:07:35 AM Argos Therapeutics To Terminate ADAPT Study; Reviews Strategic Alternatives
4/2/2018 8:40:13 AM Argos Q4 Revenue $1.7 Mln Vs. $0.2 Mln Prior Year
2/15/2018 8:36:11 AM Argos Therapeutics Announces Issuance Of Patent Covering Foundation For Manufacturing HIV Immunotherapy
2/22/2017 1:08:29 PM FBR Capital Markets Cuts Argos Therapeutics, Inc. (ARGS) To Market Perform From Outperform With $2 Price Target